Alector Inc
(NAS:ALEC)
$
1.8
-0.030 (-1.65%)
Market Cap: 199.84 Mil
Enterprise Value: 27.88 Mil
PE Ratio: 0
PB Ratio: 19.15
GF Score: 30/100 Alector Inc at Bank of America CNS Therapeutics Conference (Virtual) Transcript
Dec 08, 2025 / 07:25PM GMT
Release Date Price:
$1.22
Operator
Ladies and gentlemen, the program is about to begin. At this time. It is my pleasure to turn the program over to your host, Alex Stranahan.
Alec Stranahan
Bofa Merrill Lynch Asset Holdings Inc - Analyst
All right, great. Thank you, operator, and thanks everyone for joining the session with Alector Therapeutics, part of our BFA 2025 CNS conference. My name is Alex Stranahan, I'm Senior Biotech Analyst, covering SMICA, and Alector at Bank of America.
And I have the pleasure of being joined today by, the electoral management team, including Arnon Rosenthal, co-founder, Chief Executive Officer, and Director; Giacomo Salvadore, Chief Medical Officer; and Neil Berkley, Chief Business Officer and Interim Chief Financial Officer. Thanks guys for being here.
Arnon Rosenthal
Alector Inc - Chief Executive Officer, Co-Founder, Director
Thank you for inviting us.
Questions & Answers
Alec Stranahan
Bofa Merrill Lynch Asset Holdings Inc - Analyst
Great. Well, let
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot